NPN 80016519
Canadian patent no 2136233
|
Formulated specifically for premenopausal women.
Isoflavones help compensate the decrease in estrogen production around menopause.
May relieve symptoms associated with peri-menopause such as hot flashes and/or night sweats.
In conjunction with sufficient calcium and vitamin D intake, helps reduce the risk of adverse effects associated with transition into menopause such as bone fragilisation. |
|
Medicinal ingredients
Each capsule contains:
Total isoflavones (Phytoestrogens).................................................20 mg (or 16.35mg EIA)
From a combination of:
Kudzu isoflavones [Pueraria montana var. lobata] (roots)...........14 mg (or 10.35mg EIA)
From 35 mg of an extract standardized to 40% in isoflavones
Red clover isoflavones[Trifolium pratense] (aerial parts)....................6 mg EIA
From 75 mg of an extract standardized to 8% in isoflavones
Kudzu [Pueraria montana var. lobata] (roots).........................................40 mg
*EIA: Equivalent in Isoflavones Aglycones |
Dosage
Adults:
Take 3 capsules once or twice daily as needed.
Use for a minimum of 8-12 weeks to see beneficial effects on premenopausal symptoms.
Use for a minimum of 6 months to see beneficial effects on bone.
Consult a health care practitioner for continuous use above one year or if symptoms worsen.
Benefits & Recommended for |
|
Heavy or normal menstrual bleeding
Irregularity, longer or shorter menstrual cycles.
Enhanced bloating or cramps during or before periods.
Occasional hot flashes or night sweats.
Precautions & Adverse Effects
Ensure you are up-to-date on mammograms and gynaecological evaluations prior to use.
Do not use if you currently have or previously had breast cancer or breast tumours or if you have a predisposition to breast cancer, as indicated by an abnormal mammogram and/or biopsy, or a family member with breast cancer.
Consult a health care practitioner prior to use if you are taking blood thinners, hormone replacement therapy (HRT) including thyroid hormone replacement therapy, if you have a history of hormonal or gynaecological disease, including ovarian cancer, endometriosis, and/or uterine fibroids or if you have a liver disorder or develop liver-related symptoms (e.g. abdominal pain, jaundice, dark urine).
Discontinue use and consult a health care practitioner if you experience breast pain, discomfort and/or tenderness or if you experience a recurrence of menstruation and/or uterine spotting.
Feminex® is a registered trademark of Sante Naturelle (A.G.) Ltd
|